Search results for "RICS"

showing 10 items of 14086 documents

Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group-Italian Neurological Society

2011

Three years after the introduction of natalizumab (NA) therapy for the second line treatment of relapsing-remitting multiple sclerosis (MS), Italian MS centers critically reviewed the scientific literature and their own clinical experience. Natalizumab was shown to be highly efficacious in the treatment of MS. However, the risk of progressive multifocal leukoencephalopathy was confirmed and defined better. This article summarizes the MS-SIN Study Group recommendations on the use of NA in MS, with particular reference to the appropriate selection and monitoring of patients as well as to the management of adverse events.

medicine.medical_specialtyPediatricspml; iris; multiple sclerosis; natalizumabMultiple SclerosisNeurologypmlMEDLINEProgressive MultifocalDermatologyRelapsing-RemittingAntibodies Monoclonal HumanizedAntibodiesLeukoencephalopathyMultiple Sclerosis Relapsing-RemittingNatalizumabLeukoencephalopathyMonoclonalmedicineHumansAdverse effectAntibodies; Monoclonal; Humanized Antibodies; therapeutic use Humans Leukoencephalopathy; Progressive Multifocal; chemically induced Multiple Sclerosis; Relapsing-Remitting; drug therapyHumanizedMultiple sclerosis Natalizumab PML IRISirisbusiness.industryNatalizumabProgressive multifocal leukoencephalopathyMultiple sclerosisLeukoencephalopathy Progressive MultifocalAntibodies MonoclonalGeneral Medicinemedicine.diseasedrug therapyPsychiatry and Mental healththerapeutic usechemically inducednatalizumab multiple sclerosis treatment guidelinesPhysical therapySettore MED/26 - NeurologiaNeurology (clinical)Neurosurgerybusinessmedicine.drug
researchProduct

Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey.

2010

Mucopolysaccharidosis type II (MPS II or Hunter syndrome) is a rare, inherited disorder caused by deficiency of the lysosomal enzyme iduronate-2-sulfatase. As a result of this deficiency, glycosaminoglycans accumulate in lysosomes in many tissues, leading to progressive multisystemic disease. The cardiopulmonary and neurological problems associated with MPS II have received considerable attention. Orthopedic manifestations are common but not as well characterized. This study aimed to characterize the prevalence and severity of orthopedic manifestations of MPS II and to determine the relationship of these signs and symptoms with cardiovascular, pulmonary and central nervous system involvemen…

medicine.medical_specialtyPediatricsspine.MucopolysaccharidosisDiseaseboneArticlebone joint mucopolysaccharidosis orthopedic spinejointmedicineOrthopedics and Sports MedicineMucopolysaccharidosis type IIorthopedicOrthopedic surgerybusiness.industryHunter syndromemucopolysaccharidosismedicine.diseaseSurgeryNatural historymedicine.anatomical_structureOrthopedic surgeryAnkleRange of motionbusinessRD701-811Orthopedic reviews
researchProduct

Die kombinierte operative und radiotherapeutische Behandlung (CORT) von Beckenwandrezidiven: Erfahrungsbericht nach 3 Jahren

1993

CORT has been developed to treat recurrent gynaecological malignancies infiltrating the pelvic wall unilaterally. The surgical part consists of: (i) staging laparotomy/lymphadenectomy, (ii) maximum tumour resection at the pelvic wall and exenteration of infiltrated central pelvic organs, (iii) implantation of guiding tubes on the residual tumour/tumour bed on the pelvic wall, (iv) pelvic wall plasty with muscle, musculocutaneous and omentum flaps, (v) operative reconstruction of bowel, bladder and perineo-vulvo-vaginal functions. Radiation is performed as interstitial high dose rate brachytherapy through the implanted tubes. Patients without prior pelvic irradiation receive in addition, who…

medicine.medical_specialtyPelvic exenterationEpitheliomabusiness.industrymedicine.medical_treatmentObstetrics and GynecologyWhole-Pelvismedicine.diseaseHigh-Dose Rate BrachytherapySurgeryRadiation therapyMaternity and MidwiferymedicineCarcinomaLymphadenectomybusinessComplicationGeburtshilfe und Frauenheilkunde
researchProduct

Results of the smooth-muscle fold-over double-plasty (SMFD)

1986

Since 1980, when we developed substitute for the internal anal sphicter, the smooth-muscle fold-over double-plasty (SMFD-plasty), we have operated on seven children using this method, usually in combination with the pull-through procedure, and on five children after one or more previous operations. Since 1983, 11 cases with previous operations have undergone the modified “door-wing” SMFD-plasty. The results are excellent if the operation is used in primary combination with the pull-through procedure or if the “door-wing” modification is combined with reconstruction of the pelvic floor. It is also necessary that all cases undergo a biofeedback conditioning program.

medicine.medical_specialtyPelvic floorAnorectal diseaseFold (higher-order function)business.industryGeneral MedicineAnusSurgerymedicine.anatomical_structureSmooth musclePediatrics Perinatology and Child HealthBiofeedback conditioningmedicineSurgeryAnal sphincterbusinessPediatric Surgery International
researchProduct

Operative Therapie bei Genitaldeszensus der Frau: Pro und Kontra der Verwendung von Mesh-Materialien

2006

Die gegenwärtige Entwicklung unterschiedlicher Mesh-Materialien hat zu einer Verbesserung der individuellen operativen Sanierung des Genitalprolapses geführt. Makroporöse monofilamentäre synthetische Netze scheinen geeignet zur Verwendung beim Rezidivprolaps oder bei ausgeprägten Beckenbodeninsuffizienzen zu sein. Die Verwendung von biologischen Netzen zeigt eine deutlich bessere Verträglichkeit mit weniger Infektionen oder Erosionen, bislang ist jedoch nicht das Problem der langfristigen Haltbarkeit geklärt. Die operative Korrektur des Genitalprolapses muss alle Risiken und Nutzen zur Verbesserung der Lebensqualität abwägen, hier können Mesh- Materialien deutliche Vorteile gerade in der Re…

medicine.medical_specialtyPelvic floormedicine.anatomical_structurebusiness.industrymedicineObstetrics and GynecologyGeneral MedicineRisks and benefitsPelvic floor surgerySurgical correctionbusinessSurgeryGynäkologisch-geburtshilfliche Rundschau
researchProduct

Long-term prediction of birth weight

1993

On the basis of the hypothesis that undisturbed individual growth in fetal life keeps a constant proportional difference with the standard population 50th percentile, birth weight can be predicted with a single sonographic exploration after the 16th week of pregnancy. Data on 135 singleton pregnancies with accurate dates and delivery at term were used. Sonography was performed between the 17th and 36th weeks of pregnancy, in every case at least 4 weeks before delivery. The observed measurements of BPD, FL, and AC were used for the prediction of their values on the day of delivery, applying the Hadlock equation for the estimation of birth weight. The mean error of birth weight predictions wa…

medicine.medical_specialtyPercentileCorrelation coefficientBirth weightUltrasonography PrenatalEmbryonic and Fetal DevelopmentPredictive Value of TestsPregnancymedicineBirth WeightHumansFalse Positive ReactionsRadiology Nuclear Medicine and imagingLongitudinal StudiesLong-term predictionFetusPregnancyRadiological and Ultrasound Technologybusiness.industryObstetricsSingletonReproducibility of ResultsGestational agemedicine.diseaseSurgeryFemalebusinessJournal of Ultrasound in Medicine
researchProduct

Distribution of lymphocyte surface antigens in healthy neonates.

1994

Using flow cytometric analysis we investigated the distribution of major lymphocyte surface antigens in newborn infants. A total of 221 newborns entered the study, of whom 53 fullfilled our criteria of healthy mature neonates. Percentages of immunofluorescent-positive cells were as follows (median and range from 25th to 75th percentiles given): for CD1 3.8%; 2.3%–5.8%. CD2 60.9%; 52.4%–66.8%. CD3 57.5%; 50.5%–63.3%. TcRas 57.7%; 48.1%–60.0%. CD4 36.3%; 28.0%–42.6%. CD8 23.0%; 20.0%–27.4%. CD11a 56.3%; 46.3%–68.5%. CD19 12.1%; 8.6%–14.8%. CD20 10.9%; 8.4%–12.9%. CD25 2.6%; 2.1%–4.5%. CDw52 61.0%; 51.2%–76.1%. CD71 5.2%; 3.1%–9.3%. While the ranges for the percentage of immunofluorescent-posi…

medicine.medical_specialtyPercentilebusiness.industryLymphocyteInfant NewbornNormal valuesFetal BloodFlow CytometryGastroenterologyAntigens DifferentiationSurgerymedicine.anatomical_structureAntigenAntigens CDReference ValuesRecien nacidoInternal medicinePediatrics Perinatology and Child HealthmedicineHumansbusinessEuropean journal of pediatrics
researchProduct

A Novel Technique of Posterolateral Suturing in Thoracoscopic Diaphragmatic Hernia Repair

2017

Background Closure of the posterolateral defect in some cases of congenital diaphragmatic hernia (CDH) can be difficult. Percutaneous transcostal suturing is often helpful to create a complete, watertight closure of the diaphragm. A challenge with the technique is passing the needle out the same tract that it entered so that no skin is caught when the knots are laid down into the subcutaneous tissue. This report describes a novel technique using a Tuohy needle to percutaneously suture the posterolateral defect during thoracoscopic repair of CDH. Case We report a case of a 6-week-old infant who presented with a CDH and ipsilateral intrathoracic kidney that was repaired using thoracoscopic a…

medicine.medical_specialtyPercutaneousTuohy needlelcsh:SurgerythoracoscopyCase ReportExtracorporealcongenital diaphragmatic hernia03 medical and health sciences0302 clinical medicineSuture (anatomy)030225 pediatricsThoracoscopyMedicinetuohy needlemedicine.diagnostic_testbusiness.industrysuturing techniquelcsh:RJ1-570Congenital diaphragmatic hernialcsh:PediatricsPerioperativelcsh:RD1-811medicine.diseaseSurgeryDiaphragm (structural system)030220 oncology & carcinogenesisbusinessEuropean Journal of Pediatric Surgery Reports
researchProduct

Ovarian cysts in the fetus and neonate--changes in sonographic pattern in the follow-up and their management.

1992

In a multicenter trial we retrospectively evaluated the clinical and sonographic data of 49 neonatal ovarian cysts, 44 of which were detected prenatally and 5 on the first day after delivery. Of the 44 prenatally detected cysts 39 were purely cystic, 5 echogenic or had a mixed pattern. In 20 patients the cystic appearance changed during delivery from purely cystic to a mixed pattern being independent on the size of the cyst. 26 of the 44 cysts were treated surgically. Salpingotorsion was found in 8 and was independent on the size of the cyst. In 15 a salpingo-oophorectomy or oophorectomy was performed, in 11 the ovary was saved. 23 patients were followed sonographically: 15 cysts showed com…

medicine.medical_specialtyPercutaneousmedicine.medical_treatmentOvaryUltrasonography PrenatalPregnancyMulticenter trialparasitic diseasesmedicineHumansRadiology Nuclear Medicine and imagingCystNeuroradiologyRetrospective StudiesPregnancybusiness.industryInfant NewbornOophorectomymedicine.diseaseSurgeryFetal DiseasesOvarian Cystsmedicine.anatomical_structureIn uteroPediatrics Perinatology and Child HealthFemalebusinessFollow-Up StudiesPediatric radiology
researchProduct

Pharmacokinetics of agalsidase alfa in male and female patients with Fabry disease

2007

medicine.medical_specialtyPharmacokineticsbusiness.industryInternal medicinePediatrics Perinatology and Child HealthFemale patientmedicineGeneral Medicinemedicine.diseasebusinessAgalsidase alfaFabry diseaseActa Paediatrica
researchProduct